tradingkey.logo
tradingkey.logo
Search

ALX Oncology Holdings Inc

ALXO
Add to Watchlist
1.700USD
-0.040-2.30%
Close 09-18 16:00ET
233.59MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.30%

5 Days

-12.37%

1 Month

-18.27%

6 Months

-20.93%

Year to Date

+50.44%

1 Year

+55.96%

Key Figures

1.740Open
1.750High
368.55KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.27%Turnover Ratio
1.740Prev. Close
1.670Low
628.13KTurnover
LossP/E Static
1.72P/B
0.00%Div Yield TTM
-59.40%ROA
2.66052wk High
157.68Volume Ratio
-134.85MNet Profit
138.22MShares
-1.4903EPS TTM
0.44Beta
-74.17%ROE
1.05052wk Low
4.60%Amplitude
--Gross Margin
233.59MMarket Cap
0.31Reward/Risk
6.00%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

ALX Oncology Holdings Inc's Score

0.20vs previous score
Forecast8.00
Financial Health5.40
Technical4.79
Valuation Dimensions6.11
Institutional Confidence3.00
Risk Assessment3.76

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
4.600Target Price
+143.39%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy11111111
Buy55555533
Hold11111111
Sell00000000
Strong Sell00000000

ALX Oncology Holdings Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.13/-0.14
Revenue / Forecast
--/0.00

ALX Oncology Holdings Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolALXO
Number of employees80
CountryUnited States of America

Ownership

ShareholdersProportion
RA Capital Management, LP9.75%
VenBio Partners LLC9.58%
HBM Partners AG3.34%
Vanguard Capital Management, LLC3.11%
Shareholder TypesProportion
Private Equity10.26%
Investment Advisor9.91%
Venture Capital9.75%
Investment Advisor/Hedge Fund5.15%

FAQs

What is the current price of ALX Oncology Holdings Inc (ALXO)?

The current price of ALX Oncology Holdings Inc (ALXO) is 1.70.

What is the symbol of ALX Oncology Holdings Inc?

The ticker symbol of ALX Oncology Holdings Inc is ALXO.

What is the 52-week high of ALX Oncology Holdings Inc?

The 52-week high of ALX Oncology Holdings Inc is 2.66.

What is the 52-week low of ALX Oncology Holdings Inc?

The 52-week low of ALX Oncology Holdings Inc is 1.03.

What is the market capitalization of ALX Oncology Holdings Inc?

The market capitalization of ALX Oncology Holdings Inc is 233.59M.

Is ALX Oncology Holdings Inc (ALXO) currently rated as Buy, Hold, or Sell?

According to analysts, ALX Oncology Holdings Inc (ALXO) has an overall rating of Buy, with a price target of 4.60.

What is the Earnings Per Share (EPS TTM) of ALX Oncology Holdings Inc (ALXO)?

The Earnings Per Share (EPS TTM) of ALX Oncology Holdings Inc (ALXO) is -1.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.